You are seeing these quotes based on previous browsing related to sectors such as
| Latest | Forecast | |
|---|---|---|
| Div Yield | 0.0% | 0.0% |
| Div Cover | n/a | n/a |
| Op Mrgn | -9,470.8% | -141.7% |
| ROCE | 0.0% |
| Latest | Forecast | |
|---|---|---|
| P/E | -22.6 | 0.0 |
| PEG | 0.0 | -999,999.0 |
| Price / Revenue | 2,048.6 | 31.4 |
| Price / Book value | 23.5 |
| Latest | Forecast | |
|---|---|---|
| Revenue | n/a | 11.9% |
| PBT | 0.0% | n/a |
| EPS | 0.0% | 10.4% |
| DPS | n/a | 0.0% |
| Year Ending | Revenue (£m) |
Pre-tax (£m) |
EPS | P/E | PEG | EPS Growth | Div | Yield |
|---|---|---|---|---|---|---|---|---|
| 2016-12-31 | 0.77 | -10.36 | -12.10p | -8.3 | 0.0 | n/a | n/a | 0.0% |
| 2017-12-31 | 0.02 | -3.77 | -2.30p | -84.6 | 0.0 | n/a | n/a | 0.0% |
| 2018-12-31 | n/a | -20.53 | -26.20p | -2.0 | 0.0 | n/a | n/a | 0.0% |
| 2019-12-31 | 0.24 | -22.87 | -26.10p | -13.4 | 0.0 | n/a | n/a | 0.0% |
| Silence to get $2m milestone payment from Mallinckrodt Sharecast News | 26 Feb |
|---|---|
| Silence Therapeutics begins dosing in lipoprotein treatment trial Sharecast News | 17 Feb |
| Silence Therapeutics raises £33m to support pipeline development Sharecast News | 05 Feb |
| Silence & Mallinckrodt Initiate Work on 3rd Target | 26-Feb-21 07:01 |
|---|---|
| Holding(s) in Company | 24-Feb-21 15:10 |
| Silence to Partake in March Investor Conferences | 22-Feb-21 07:00 |
| Silence to present at SVB Leerink Conference | 18-Feb-21 07:00 |
| First dosing for SLN360 | 17-Feb-21 07:00 |